阿尔茨海默-话题@MedSci

#阿尔茨海默#

756篇内容 | 7926人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1470365, encodeId=8eeb14e0365cc, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, objectTitle=JAMA Neurol:KL-VSHET+基因型与较低的阿尔茨海默病风险, objectType=article, longId=192281, objectId=b3d8192281c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3d8192281c3, replyNumber=0, likeNumber=53, createdTime=2020-04-16, rootId=0, userName=yhj-time, userId=c5917090900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3d8192281c3, moduleTitle=JAMA Neurol:KL-VSHET+基因型与较低的阿尔茨海默病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3d8192281c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1470364, encodeId=b13014e036431, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, objectTitle=Sci Bull：海马影像组学是阿尔茨海默病早期识别标记, objectType=article, longId=192256, objectId=3f8819225649, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f8819225649, replyNumber=0, likeNumber=81, createdTime=2020-04-16, rootId=0, userName=yhj-time, userId=c5917090900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f8819225649, moduleTitle=Sci Bull：海马影像组学是阿尔茨海默病早期识别标记, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f8819225649)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1470363, encodeId=2b5114e03633d, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, objectTitle=Biogen以27亿美元与基因编辑公司Sangamo签署协议，再次在阿尔茨海默氏病领域巨额投资, objectType=article, longId=189183, objectId=0b3318918384, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b3318918384, replyNumber=0, likeNumber=73, createdTime=2020-03-04, rootId=0, userName=yhj-time, userId=c5917090900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b3318918384, moduleTitle=Biogen以27亿美元与基因编辑公司Sangamo签署协议，再次在阿尔茨海默氏病领域巨额投资, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b3318918384)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1470362, encodeId=184e14e036201, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, objectTitle=Clinica Chimica Acta：早期阿尔茨海默病中胆碱能和5 -羟色胺能系统的血浆改变, objectType=article, longId=189137, objectId=a3a518913e0a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3a518913e0a, replyNumber=0, likeNumber=79, createdTime=2020-03-03, rootId=0, userName=yhj-time, userId=c5917090900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3a518913e0a, moduleTitle=Clinica Chimica Acta：早期阿尔茨海默病中胆碱能和5 -羟色胺能系统的血浆改变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3a518913e0a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1470361, encodeId=e54b14e036184, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, objectTitle=Life Sci Alliance：脑衰老率和APOEε4是阿尔茨海默氏病的协同危险因素, objectType=article, longId=188993, objectId=d4a418899344, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4a418899344, replyNumber=0, likeNumber=74, createdTime=2020-03-01, rootId=0, userName=yhj-time, userId=c5917090900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4a418899344, moduleTitle=Life Sci Alliance：脑衰老率和APOEε4是阿尔茨海默氏病的协同危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4a418899344)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1470360, encodeId=daff14e0360b9, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, objectTitle=又一个中晚期阿尔茨海默症药物失败，这次是礼来公司, objectType=article, longId=188060, objectId=652d1880608f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=652d1880608f, replyNumber=0, likeNumber=73, createdTime=2020-02-16, rootId=0, userName=yhj-time, userId=c5917090900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=652d1880608f, moduleTitle=又一个中晚期阿尔茨海默症药物失败，这次是礼来公司, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=652d1880608f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1470359, encodeId=d7be14e0359ab, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, objectTitle=罗氏宣布其阿尔茨海默氏症单抗gantenerumab临床实验失败, objectType=article, longId=187845, objectId=85b418e84596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85b418e84596, replyNumber=0, likeNumber=77, createdTime=2020-02-13, rootId=0, userName=yhj-time, userId=c5917090900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85b418e84596, moduleTitle=罗氏宣布其阿尔茨海默氏症单抗gantenerumab临床实验失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85b418e84596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1470358, encodeId=62da14e03586f, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, objectTitle=曙光初现：阻止或减缓阿尔茨海默症状出现的药物或已问世, objectType=article, longId=187726, objectId=887518e726dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=887518e726dc, replyNumber=0, likeNumber=60, createdTime=2020-02-10, rootId=0, userName=yhj-time, userId=c5917090900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=887518e726dc, moduleTitle=曙光初现：阻止或减缓阿尔茨海默症状出现的药物或已问世, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=887518e726dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1470357, encodeId=102414e0357db, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, objectTitle=默克向FDA申请，将Belsomra用于治疗阿尔茨海默氏症患者的睡眠障碍, objectType=article, longId=187479, objectId=318b18e47983, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=318b18e47983, replyNumber=0, likeNumber=61, createdTime=2020-02-06, rootId=0, userName=yhj-time, userId=c5917090900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=318b18e47983, moduleTitle=默克向FDA申请，将Belsomra用于治疗阿尔茨海默氏症患者的睡眠障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=318b18e47983)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1470356, encodeId=1d3814e03561e, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, objectTitle=Neurology：膳食中黄酮醇摄入量与阿尔茨海默症的风险, objectType=article, longId=187078, objectId=d82c18e07805, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d82c18e07805, replyNumber=0, likeNumber=89, createdTime=2020-02-02, rootId=0, userName=yhj-time, userId=c5917090900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d82c18e07805, moduleTitle=Neurology：膳食中黄酮醇摄入量与阿尔茨海默症的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d82c18e07805)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1470355, encodeId=59ce14e0355da, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, objectTitle=FDA已接受ADLARITY（多奈哌齐透皮系统）的NDA以治疗阿尔茨海默病, objectType=article, longId=186923, objectId=4f8d18692353, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f8d18692353, replyNumber=0, likeNumber=76, createdTime=2020-01-30, rootId=0, userName=yhj-time, userId=c5917090900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f8d18692353, moduleTitle=FDA已接受ADLARITY（多奈哌齐透皮系统）的NDA以治疗阿尔茨海默病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f8d18692353)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1470354, encodeId=4aef14e03545f, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, objectTitle=锂能阻止阿尔茨海默症的进展吗？, objectType=article, longId=186813, objectId=fe0d1868135a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe0d1868135a, replyNumber=0, likeNumber=97, createdTime=2020-01-29, rootId=0, userName=yhj-time, userId=c5917090900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe0d1868135a, moduleTitle=锂能阻止阿尔茨海默症的进展吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe0d1868135a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1470353, encodeId=ce1714e0353cb, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, objectTitle=Theranexus宣布1b期研究结果，证明与多奈哌齐相比，其阿尔茨海默氏病候选药物THN201的药理学特性得到了扩展, objectType=article, longId=186520, objectId=88ea186520c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88ea186520c4, replyNumber=0, likeNumber=17, createdTime=2020-01-20, rootId=0, userName=yhj-time, userId=c5917090900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88ea186520c4, moduleTitle=Theranexus宣布1b期研究结果，证明与多奈哌齐相比，其阿尔茨海默氏病候选药物THN201的药理学特性得到了扩展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88ea186520c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1470352, encodeId=1ea114e035215, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, objectTitle=Neurology：阿尔茨海默病患者出血性和缺血性卒中风险, objectType=article, longId=186517, objectId=409418651e31, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=409418651e31, replyNumber=0, likeNumber=64, createdTime=2020-01-20, rootId=0, userName=yhj-time, userId=c5917090900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=409418651e31, moduleTitle=Neurology：阿尔茨海默病患者出血性和缺血性卒中风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=409418651e31)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1470351, encodeId=977a14e0351e8, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, objectTitle=Neurology：年轻人也要当心！研究发现通宵一晚就会增加阿尔茨海默症标志物, objectType=article, longId=186341, objectId=4677186341df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4677186341df, replyNumber=0, likeNumber=76, createdTime=2020-01-18, rootId=0, userName=yhj-time, userId=c5917090900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4677186341df, moduleTitle=Neurology：年轻人也要当心！研究发现通宵一晚就会增加阿尔茨海默症标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4677186341df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1470350, encodeId=909114e0350b5, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, objectTitle=Nature：阿尔茨海默病患者脑脊液惊现免疫T细胞！, objectType=article, longId=186300, objectId=d8441863004e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8441863004e, replyNumber=0, likeNumber=60, createdTime=2020-01-16, rootId=0, userName=yhj-time, userId=c5917090900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8441863004e, moduleTitle=Nature：阿尔茨海默病患者脑脊液惊现免疫T细胞！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8441863004e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1470349, encodeId=834e14e034961, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, objectTitle=Biogen将从辉瑞购买实验性阿尔茨海默症/帕金森病药物PF-05251749, objectType=article, longId=186231, objectId=eaa1186231a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eaa1186231a9, replyNumber=0, likeNumber=51, createdTime=2020-01-15, rootId=0, userName=yhj-time, userId=c5917090900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eaa1186231a9, moduleTitle=Biogen将从辉瑞购买实验性阿尔茨海默症/帕金森病药物PF-05251749, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eaa1186231a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1470348, encodeId=69e814e0348e3, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, objectTitle=绿谷药业宣布将在全球200个临床中心，开展阿尔茨海默症新药GV-971的全球临床试验, objectType=article, longId=185844, objectId=b18018584449, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b18018584449, replyNumber=0, likeNumber=133, createdTime=2020-01-08, rootId=0, userName=yhj-time, userId=c5917090900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b18018584449, moduleTitle=绿谷药业宣布将在全球200个临床中心，开展阿尔茨海默症新药GV-971的全球临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b18018584449)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1470347, encodeId=613514e034701, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, objectTitle=Neurology：新量表定义精细认知障碍，非侵入性预测阿尔茨海默病！, objectType=article, longId=185800, objectId=cf2d18580002, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf2d18580002, replyNumber=0, likeNumber=129, createdTime=2020-01-07, rootId=0, userName=yhj-time, userId=c5917090900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf2d18580002, moduleTitle=Neurology：新量表定义精细认知障碍，非侵入性预测阿尔茨海默病！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf2d18580002)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1470346, encodeId=0ebe14e034625, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, objectTitle=2019年阿尔茨海默病十大临床研究进展, objectType=article, longId=185766, objectId=3e72185e660a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e72185e660a, replyNumber=0, likeNumber=86, createdTime=2020-01-07, rootId=0, userName=yhj-time, userId=c5917090900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e72185e660a, moduleTitle=2019年阿尔茨海默病十大临床研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e72185e660a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

阿尔茨海默

2020-05-29

yhj-time (审核中...)

前往app查看评论内容

#阿尔茨海默#

JAMA Neurol:KL-VSHET+基因型与较低的阿尔茨海默病风险

2020-04-16

yhj-time (审核中...)

前往app查看评论内容

#阿尔茨海默#

Sci Bull：海马影像组学是阿尔茨海默病早期识别标记

2020-04-16

yhj-time (审核中...)

前往app查看评论内容

#阿尔茨海默#

Biogen以27亿美元与基因编辑公司Sangamo签署协议，再次在阿尔茨海默氏病领域巨额投资

2020-03-04

yhj-time (审核中...)

前往app查看评论内容

#阿尔茨海默#

Clinica Chimica Acta：早期阿尔茨海默病中胆碱能和5 -羟色胺能系统的血浆改变

2020-03-03

yhj-time (审核中...)

前往app查看评论内容

#阿尔茨海默#

Life Sci Alliance：脑衰老率和APOEε4是阿尔茨海默氏病的协同危险因素

2020-03-01

yhj-time (审核中...)

前往app查看评论内容

#阿尔茨海默#

又一个中晚期阿尔茨海默症药物失败，这次是礼来公司

2020-02-16

yhj-time (审核中...)

前往app查看评论内容

#阿尔茨海默#

罗氏宣布其阿尔茨海默氏症单抗gantenerumab临床实验失败

2020-02-13

yhj-time (审核中...)

前往app查看评论内容

#阿尔茨海默#

曙光初现：阻止或减缓阿尔茨海默症状出现的药物或已问世

2020-02-10

yhj-time (审核中...)

前往app查看评论内容

#阿尔茨海默#

默克向FDA申请，将Belsomra用于治疗阿尔茨海默氏症患者的睡眠障碍

2020-02-06

yhj-time (审核中...)

前往app查看评论内容

#阿尔茨海默#

Neurology：膳食中黄酮醇摄入量与阿尔茨海默症的风险

2020-02-02

yhj-time (审核中...)

前往app查看评论内容

#阿尔茨海默#

FDA已接受ADLARITY（多奈哌齐透皮系统）的NDA以治疗阿尔茨海默病

2020-01-30

yhj-time (审核中...)

前往app查看评论内容

#阿尔茨海默#

锂能阻止阿尔茨海默症的进展吗？

2020-01-29

yhj-time (审核中...)

前往app查看评论内容

#阿尔茨海默#

Theranexus宣布1b期研究结果，证明与多奈哌齐相比，其阿尔茨海默氏病候选药物THN201的药理学特性得到了扩展

2020-01-20

yhj-time (审核中...)

前往app查看评论内容

#阿尔茨海默#

Neurology：阿尔茨海默病患者出血性和缺血性卒中风险

2020-01-20

yhj-time (审核中...)

前往app查看评论内容

#阿尔茨海默#

Neurology：年轻人也要当心！研究发现通宵一晚就会增加阿尔茨海默症标志物

2020-01-18

yhj-time (审核中...)

前往app查看评论内容

#阿尔茨海默#

Nature：阿尔茨海默病患者脑脊液惊现免疫T细胞！

2020-01-16

yhj-time (审核中...)

前往app查看评论内容

#阿尔茨海默#

Biogen将从辉瑞购买实验性阿尔茨海默症/帕金森病药物PF-05251749

2020-01-15

yhj-time (审核中...)

前往app查看评论内容

#阿尔茨海默#

绿谷药业宣布将在全球200个临床中心，开展阿尔茨海默症新药GV-971的全球临床试验

2020-01-08

yhj-time (审核中...)

前往app查看评论内容

#阿尔茨海默#

Neurology：新量表定义精细认知障碍，非侵入性预测阿尔茨海默病！

2020-01-07

yhj-time (审核中...)

前往app查看评论内容

#阿尔茨海默#

2019年阿尔茨海默病十大临床研究进展

2020-01-07

科室
- - 订阅+
  - 更多科室
工具
服务